BRIEF-Watson gets approval from European commission to buy Actavis
Oct 5 (Reuters) - Watson Pharmaceuticals Inc :
* Receives approval from European commission for pending actavis acquisition
* Says transaction remains subject to regulatory approval in the United States
from the federal trade commission
* Says Watson continues to expect the transaction to close in the fourth
quarter of 2012
((Bangalore Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
((For more news, please click here ))
Trending Now